Ibrahim B. Dagher Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity
Ibrahim B. Dagher is Chief Medical Officer of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 0 shares of BCLI, which is worth approximately $0. The most recent transaction as insider was on Jul 19, 2024, when has been sold 63,000 shares (Common Stock) at a price of $0.35 per share, resulting in proceeds of $22,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
n/a
12M change
Total Value Held
$0
IBD
Ibrahim B. Dagher
Chief Medical Officer
New York, NY